EUTM file information

018272742

Semefro


July 13, 2020

Trademark Summary

The trademark Semefro was filed by Swyssi, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on August 6, 2020, and received one opposition filed on October 13, 2020 by Novartis AG on Likelihood of confusion. the opponent was represented by WEGNERPARTNER and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 13, 2020

The application was filed in Bulgarian, and Bulgarian was also language of all opposition proceedings (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on October 25, 2020.

The Opposition with reference B 003132615 was refused according to Article 8(1)(b) EUTMR with decision issued on December 2, 2021 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Anti-diabetic pharmaceuticals
    2. Pharmaceutical preparations for treating diabetes
    3. Pharmaceutical preparations for the prevention of diabetes.